Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease.
Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders.
Elekta's systems and solutions are used in over 4,500 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife(R) for non-invasive treatment of brain disorders, Elekta Axesse(TM) and Elekta Synergy(R) for stereotactic and image guided radiation therapy and radiosurgery, PrecisePLAN and ERGO++ treatment planning systems as well as the MOSAIQ(TM) suite of software for image-enabled EMR and efficient management of clinical and patient data.
With over 2,000 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta is available at http://www.elekta.com.
Statements contained in this release, which are not historical facts,
may be considered "forward-looking statements" under the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are based on
current expectations and the current economic environment. We caution the
reader that such forward-looking statements are not guarantees of future
performance. Unknown risk, unc
|SOURCE Elekta, Inc.|
Copyright©2008 PR Newswire.
All rights reserved